Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 6 March 2020, 22:00 HKT/SGT
Share:
    

Source: Novotech
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea

SEOUL, KOREA, Mar 6, 2020 - (ACN Newswire) - Asia-Pacific's largest specialist biotech CRO Novotech has been selected for the Komipharm International clinical trials of Panaphix as a potential treatment for coronavirus - Covid-19.




Komipharm says Panaphix is a cytokine storm inhibitor that restrains the overproduction of immune cells and their activating compounds, cytokines. It is thought than an overproduction of immune cells and their signalling molecules causes the severe inflammatory disease such as pneumonia in some individuals.

The company said it seeks to expand the use of Panaphix to cover COVID-19 treatment through this proposed clinical trial.

Novotech CEO Dr Moller said Novotech was well positioned to partner with Komipharm International on an important drug trial that is having a particularly strong impact in Asia Pacific. Novotech has offices in eleven locations throughout Asia Pacific.

He said Novotech's model of having experienced local leadership, the ability to engage with regulators and strong relationships with Key Opinion Leaders and sites in the region will allow it to accelerate this trial.

Novotech undertakes a large number of infectious diseases trials and has particularly strong relationships in this area.

Novotech recently won the Australian-Korean Business Awards 2020 - Award for Excellence, in the category Biotech and Health.

Over the last 12 months Novotech has signed several formal partnerships with key hospitals in the country, including Seoul National University, Asan Medical Center, Yonsei University Severance Hospital, and Ulsan University Hospital, to facilitate the project management of clinical trials and accelerate biotech drug development.

About Novotech
Headquartered in Sydney, Novotech is internationally recognized as the leading regional full-service contract research organization (CRO). Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.

Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners. https://novotech-cro.com/welcome

For RFP enquiries: Please fill out the form available at www.novotech-cro.com/contact-us-0

Media Contact:
Susan Fitzpatrick-Napier
[email protected]
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427


Mar 6, 2020 22:00 HKT/SGT
Topic: Press release summary
Sectors: BioTech, HealthCare
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Novotech
Aug 26, 2020 10:00 HKT/SGT
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year'
July 13, 2020 19:00 HKT/SGT
Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can Tap the Region
June 18, 2020 11:00 HKT/SGT
Novotech Partners with South Korea's Pusan National University Hospital
May 26, 2020 19:00 HKT/SGT
Novotech and Endpoints to present APAC Clinical Trial webinar series
Apr 29, 2020 21:00 HKT/SGT
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
Apr 28, 2020 19:00 HKT/SGT
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
Apr 8, 2020 18:00 HKT/SGT
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
Mar 20, 2020 20:30 HKT/SGT
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
Jan 21, 2020 10:40 HKT/SGT
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
July 11, 2019 11:00 HKT/SGT
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
More news >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: